2022 Speakers

These are the currently confirmed expert speakers for the
4th Allogeneic Cell Therapies Summit.
Get more information in the Full Event Guide.

2022 EVENT GUIDE

Joanna Brewer

SVP Allogeneic Research

Adaptimmune

Blake Aftab

CSO

Adicet Bio

Donald Healy

CTO

Adicet Bio

Barbra Sasu

CSO

Allogene

Luke Pase

CTO

Anocca

Oscar Segurado

CMO

ASC Therapeutics

Pascal Touchon

CEO

Atara Biotherapeutics

James Glover

SVP, Commercial Manufacturing

Athersys

Maia Hansen

SVP & Head of Operations & Supply Chain

Athersys

Charles Mooney

CEO

BioSharing Network

Deyaa Adib

CMO

Triumvira Immunologics

Yuechen Zhu

Process Development Scientist

Bayer

Alden Ladd

Associate Director, Cellular Process Development

Beam Therapeutics

Chia-Hsing Pi

Scientist II, Process Development

BlueRock Therapeutics

Wendy Larson

Director, Regulatory Affairs (CMC)

BlueRock Therapeutics

Katie Pollock

Head of Formulation & Cryobiology

BMS

Elizabeth Garner

Director, T Cell Therapeutics

Caribou Biosciences

Alan Trounson

CEO

Cartherics

Nicholas Boyd

Chief Development Officer

Cartherics

Joseph Gold

VP, Technical Operations & Manufacturing

Catamaran Bio

Vipin Suri

CSO

Catamaran Bio

Beatriz Aranda Orgilles

Senior Scientist & Team Leader, Immuno- Oncology

Cellectis

Carrie Brownstein

CMO

Cellectis

Bradley Glover

CTO

Celularity

Matthew Johnson

Senior Director, Manufacturing Science & Technology

Cellectis

Sicco Popma

CEO

IO Biosciences

Marcos Langtry

Head of Commercial Development Allogeneic Cell Therapy

Lonza

Roman Shapiro

Attending Physician, Bone Marrow Transplantation

Dana-Faber Cancer Institute

Derek Dashti

CEO

D&P Bioinnovations

Erika von Euw

VP, Discovery and Translational Research

Deverra Therapeutics

Elena Spanjaard

VP, Early Development Regulatory Affairs

Elevate Bio

Oren Hershkovitz

CEO

Enlivex Therapeutics

Sicco Popma

CEO

IO Biosciences

Daniel Bright

Global Program Director, Global Technical Operations

Ferring Pharmaceuticals

Colleen Delaney

Founder, CSO & EVP, Research & Development

Deverra Therapeutics

Hans Klingemann

CSO

ImmunityBio

Kate Rochlin

COO

IN8Bio

William Ho

CEO

IN8Bio

Austin Bigley

VP, Director of Research & Development

Indapta Therapeutics

Christopher Ballas

SVP, Manufacturing

Innovative Cellular Therapeutics

Evren Alici

Head of Cell & Gene Therapy

Karolinska Institute

Brian Culley

CEO

Lineage Cell Therapeutics

Bertie MacArthur

Account Manager

Beacon Targeted Therapies

Mark Exley

SAB Member & Senior Advisor

MiNK Therapeutics

Carl Simon

Biologist

National Institute of Standards & Technology

Sumona Sarkar

Biomedical Engineer

National Institute of Standards & Technology

Robert Ang

CEO

Vor Biopharma

Ralph Brandenberger

VP, Development & Manufacturing

Nkarta Therapeutics

Stephen Chen

TBC

TBC

Emily Titus

VP, Process Sciences

Notch Therapeutics

Eric Halioua

CEO

PDC*Line Pharma

Lior Raviv

CTO

Pluristem Therapeutics

Greg Whitehead

Chief Quality Officer

Rubius Therapeutics

Spencer Fisk

SVP & CTOO

Rubius Therapeutics

Sonja Schrepfer

SVP, Head of Hypo- Immune Platform

Sana Biotechnology

Tim Jansen

Director, Product Supply Chain Lead

Sana Biotechnology

Brian Garrison

Director, Research

Senti Biosciences

Martin Giedlin

VP, Head of Technical Operations

Senti Biosciences

Amy McCord

Director, Global Regulatory Affairs, CMC Cell Therapy

Takeda

Benjamin Gysi

Director, Cell Therapy Operations

Takeda

Michael Leek

Co-Founder & Executive Chairman

TC BioPharm

Rakibou Ouro- Djobo

Associate Director, Clinical Supply Chain

TCR2 Therapeutics

Peggy Sotiropoulou

CSO

T-Knife Therapeutics

Jason Acker

Professor, Department of Laboratory Medicine & Pathology

University of Alberta

Allison Hubel

Professor, Department of Mechanical Engineering & Director, Technological Leadership Institute

University of Minnesota

James Ankrum

Associate Professor, Biomedical Engineering

University of Iowa

Brian Van Tine

Professor, Medicine & Pediatrics

Washington University School of Medicine in St. Louis

Rong Fan

Professor, Biomedical Engineering

Yale University

Luise Weigand

Head of Research

Zelluna Immunotherapy

Aaron Posey

EVP, Bloodworks Bio

Bloodworks Northwest

Christina Coughlin

CEO

CytoImmune Therapeutics

Dominic Clarke

CTO, Cell & Gene Therapy

Discovery Life Sciences

Robert Margolin

VP, Sales

Akron Biotech

Francesca Gullo

Scientific Director

Gift of Life Biologics

Nathan Jorgensen

CFO

Vor Biopharma

Ashish Kothari

VP, Clinical Development, Cell Transplant Therapy

CareDx

Michael Francis

Process Development Scientist

Catalent Cell & Gene Therapy

Arthur Stril

CBO

Cellectis

Joy Aho

Director, Product Management

Be The Match BioTherapies

Richard Wilner

Head of Business Excellence & Sustainability, BioLife Plasma Services

Takeda